Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postmenopausal hypertension.

L M Harrison-Bernard1, L Raij

  • 1Department of Physiology SL39, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112-2699, USA.

Current Hypertension Reports
|September 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetically conditioned interaction among microRNA-155, alpha-klotho, and intra-renal RAS in male rats: Link to CKD progression.

Physiological reports·2024
Same author

High fat diet consumption differentially affects adipose tissue inflammation and adipocyte size in obesity-prone and obesity-resistant rats.

International journal of obesity (2005)·2017
Same author

Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on endothelial nitric oxide production.

Hypertension (Dallas, Tex. : 1979)·2001
Same author

Cigarette smoke-induced endothelium dysfunction: role of superoxide anion.

Journal of hypertension·2001
Same author

Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension.

Hypertension (Dallas, Tex. : 1979)·2001
Same author

Workshop: hypertension and cardiovascular risk factors: role of the angiotensin II-nitric oxide interaction.

Hypertension (Dallas, Tex. : 1979)·2001
Same journal

Neural Control of Tissue Perfusion: Emerging Evidence and Beyond.

Current hypertension reports·2026
Same journal

Correction to: Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
Same journal

Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease.

Current hypertension reports·2026
Same journal

Combined Aldosterone Synthase and SGLT2 Inhibition: A Recipe for Success in CKD with Uncontrolled Blood Pressure?

Current hypertension reports·2026
Same journal

Leveraging the Electronic Health Record to Identify and Manage Resistant Hypertension.

Current hypertension reports·2026
Same journal

Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
See all related articles

Hormone replacement therapy (HRT) may benefit postmenopausal women with hypertension by potentially reducing blood pressure. Further research is needed to understand HRT

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Women's Health

Background:

  • Cardiovascular disease (CVD) is the leading cause of death in women, with hypertension as a major risk factor.
  • Postmenopausal women experience a higher prevalence of hypertension compared to men after age 55.
  • Estrogen deficiency following menopause is linked to increased CVD risk.

Purpose of the Study:

  • To investigate the effects of hormone replacement therapy (HRT) on blood pressure in postmenopausal women with hypertension.
  • To explore the potential cardioprotective mechanisms of estrogen in vascular health.

Main Methods:

  • The study reviews existing literature on HRT, estrogen's vascular effects, and hypertension in postmenopausal women.
  • Analysis of experimental evidence regarding estrogen's modulation of nitric oxide and angiotensin pathways.

Related Experiment Videos

Main Results:

  • Hormone replacement therapy (HRT) has demonstrated potential in reducing cardiovascular disease incidence and blood pressure in some postmenopausal women.
  • Estrogen may exert cardioprotective effects through direct vascular actions and lipid profile improvements.
  • Loss of estrogen's vascular protection post-menopause may reveal a predisposition to hypertension.

Conclusions:

  • Further research is warranted to elucidate the specific effects of HRT on blood pressure in hypertensive postmenopausal patients.
  • Understanding estrogen's role in vascular regulation is crucial for managing hypertension and CVD in women.
  • HRT could be a potential therapeutic strategy for managing hypertension in this demographic.